Drug Use Current Events | Drug Use News | 2
|
| Page
2 of
24 |
472 Results |
|
|
|
Sort By:
Page Views | Date |
U of M researchers discover new method to combat HIV
Researchers at the University of Minnesota's Center for Drug Design have developed a new method to combat HIV/AIDS, potentially replacing the traditional cocktail drug approach. view more (2007-07-24)
Garlic chemical tablet treats diabetes I and II
A drug based on a chemical found in garlic can treat diabetes types I and II when taken as a tablet, a study in the new Royal Society of Chemistry journal Metallomics says. view more (2008-11-20)
When antidepressant drugs stop working: A novel approach
Tolerance to antidepressant drug treatment is an important clinical problem (one third of cases). It may manifest as loss of clinical effect (an antidepressant drug which was working stops doing so) or resistance (a patient, after a drug-free period, fails to respond to an antidepressant drug which was effective before). There is no current... view more... (2003-05-06)
Abrupt withdrawal of drugs to prepare for surgery can be dangerous
(Editorial: The risks of interrupting drug treatment before surgery) Abruptly stopping drug treatments before surgery can be dangerous and increase the risk of postoperative complications, suggests an editorial in this week?s BMJ. Surgery, particularly major abdominal surgery, affects the rate at which stomach contents are emptied, so reducing... view more... (2000-09-19)
Developing better methods of 'blinding' doctors and patients in clinical trials
When trials are carried out to assess the effectiveness of a drug, it is an important to have a control group of patients who are not given the drug. view more (2006-10-31)
Adding steroid drug to MS treatment may reduce disease activity
Using a steroid drug for multiple sclerosis (MS) in addition to an MS drug may reduce the amount of disease activity more than using the MS drug alone. view more (2009-04-30)
Disease activity increases after MS patients stop drug
People with multiple sclerosis who stop taking the drug natalizumab may experience a rebound increase in disease activity. view more (2007-09-13)
Illegal drug use could account for 1 million visits a year to emergency care in England
Illegal drug use could account for up to 1 million visits a year to emergency care departments and 400,000 admissions to hospital in England, suggests research in Emergency Medicine Journal. view more (2005-11-17)
XDR TB in South Africa traced to lack of drug susceptibility testing
In South Africa, the 2001 implementation of the World Health Organization's anti-tuberculosis program may have inadvertently helped to create a new strain of extensively drug-resistant tuberculosis (XDR TB). view more (2007-10-23)
Doubts raised about illegal drug use surveys
A scientific study reported in two related articles in the Journal of Drug Issues raises serious doubts about the nation's illegal drug use surveillance programs. view more (2006-03-03)
One in four hospital prescribing errors “potentially serious”
Around one in four hospital drug errors is “potentially serious,” and likely to harm patients, suggests a pilot study from one major teaching hospital, reported in Quality and Safety in Health Care. view more (2002-12-03)
European drug regulations need to change, say experts
European drug regulations need changing to ensure they meet the needs of patients and doctors, argue experts in this week's BMJ. view more (2007-10-19)
Cardiac stent patients with diabetes may benefit from drug that counteracts the effects of leptin
The naturally high levels of leptin in diabetic patients may reduce the effectiveness of drug-eluting stents used to treat heart blockages, but using a chemical that differs from the one commonly used to coat stents could counteract this effect. view more (2008-12-18)
Prison drug services in Kent, Surrey and Sussex failed by lack of aftercare available to prisoners after release
The greatest threat to the success of prison-based drug treatments is the lack of aftercare available to prisoners after their release, according to a review published by the Centre for Health Service Studies at the University of Kent. The review, which is part of a wider programme of work evaluating the outcome effectiveness of drug treatment... view more... (2003-07-11)
High prescribing family doctors much more likely to see drug company reps frequently
Family doctors with high annual drug bills for their practices are significantly more likely to see drug company reps almost every day or at least once a week, reveals a representative survey of General Practitioners in England. view more (2003-02-04)
'Erasing' drug-associated memories may stop drug addiction relapses
'Erasing' drug-associated memories may prevent recovering drug abusers from relapsing, researchers at the University of Cambridge have discovered. view more (2008-08-13)
Why are the best malaria drugs not being used in Africa?
Despite changes in policy in many African countries, most cases of malaria are still treated with old drugs that often fail, say researchers in this week's BMJ. view more (2005-09-30)
'LOTRONEX AND THE FDA: A FATAL EROSION OF INTEGRITY' (p 1544)
Controversy surrounding the licensing of Lotronex (a drug for irritable bowel syndrome (IBS)) and the US Food and Drug Administration (FDA) is uncovered in a Commentary article in this week's issue of THE LANCET. In March last year THE LANCET published a randomised trial detailing the efficacy and safety of alosetron (Lotronex) for women with IBS.... view more... (2001-05-16)
Drug Related Death Risk Greater for Older Injectors
Research published today suggests older drug injectors in Scotland could be up to six times more likely to die from drug-related causes than younger ones. A team of researchers led by Professor Sheila Bird from the Medical Research Council (MRC) also found that Scottish women who inject drugs are less likely to die from drugs-related causes than... view more... (2003-09-18)
Advances in nebulised drug delivery
AROUND £50 million of National Health Service money a year is spent nebulising drug aerosols to patients with asthma, cystic fibrosis and infections. Drug delivery by this route currently escapes attention from the regulatory authorities because the drug is sold separately from the delivery device and clinical practice is based largely on... view more... (2000-01-31)
|
|
| Page
2 of
24 |
472 Results |
|
|
|
Sort By:
Page Views | Date |
|
